ARTE: Laparoscopic "DA VINCI" Robot Assisted Abdominal Wall Hernia Repair

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT00908193
Collaborator
(none)
70
1
2
59
1.2

Study Details

Study Description

Brief Summary

The aim of this study is to prove the superiority of the robotic assistance in laparoscopic repair of abdominal wall hernias .

In this monocentric randomized controlled trial, the use of the DA VINCI robot might reduce the post-operative pain of the patient resulting in a 40% reduction of morphine consumption.

Condition or Disease Intervention/Treatment Phase
  • Device: Laparoscopic DA VINCI Robot Assisted coelioscopy
  • Procedure: conventional coelioscopy
Phase 4

Detailed Description

Laparoscopic Robot Assisted abdominal wall hernia repair : a prospective randomized trial:

The main judgement criterion is post operative pain reflected by morphine consumption during the first 48 hours. Secondary criteria are morbidity, quality of life, duration of surgery, conversion rate, complications, the the length of stay and hospital costs.

In this single centre study, inclusion criteria are age above 18, no previous repair of the hernia with a mesh and a diameter of the parietal defect of less than 10 cm. Contraindications are chronic use of pain drugs of level II or above and renal insufficiency (clearance <30ml/min).

The robotic repair was described in a previous paper of our group and will be compared to our classical laparoscopic repair technique, and in both cases with the use of the same prosthetic mesh.

A total of 70 patients to be included in an 18 months period was calculated to prove a 40% reduction in morphine consumption during the postoperative 48h (α=5% and β=10%).

The total duration of the study is 30 months (12 months of follow-up for each patient).

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Assistance Robotics for the Surgical Treatment of the Abdominal Wall Hernia
Study Start Date :
Jul 1, 2007
Actual Primary Completion Date :
Jun 1, 2012
Actual Study Completion Date :
Jun 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

robot-assisted coelioscopy

Device: Laparoscopic DA VINCI Robot Assisted coelioscopy
Patients with abdominal wall hernia will be treated by robot-assisted coelioscopy for the poses of abdominal plate
Other Names:
  • Laparoscopic DA VINCI Robot Assisted abdominal coelioscopy
  • Active Comparator: 2

    conventional coelioscopy

    Procedure: conventional coelioscopy
    Patients with abdominal wall hernia will be treated by conventional coelioscopy for the poses of abdominal plate

    Outcome Measures

    Primary Outcome Measures

    1. Evaluate the reduction in morphine consumption [during the postoperative 48h]

    Secondary Outcome Measures

    1. Pain patient (ENS, total consumption of morphine) [during the hospitalization, to 10 days,1 month, 6 months and 12 months of surgery]

    2. quality of life (questionary SF-36) [1 month, 6 month and 12 month of surgery]

    3. length of stay in hospital, percentage return home to 24 hours of surgery [to 24 hours of surgery]

    4. morbidity [during the study]

    5. resumption of work [after surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • over 18 years

    • with indication of hernia repair

    • a collar with a diameter of less than 10cm

    • no antecedent of hernia treatment with poses plate

    • agreeing coelioscopy

    • agreeing to participate the clinical study, having sign an informed consent

    • agreeing a regular monitor

    Exclusion Criteria:
    • taking analgesic tier 2 or 3

    • against indication to anesthetics or coelioscopy

    • creatinine clearance less than 30 ml/min

    • pregnant woman and protected persons

    • no affiliation to social security

    • unable to understand the information form

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Groupe Hospitalier Chenevier-Mondor Créteil France 94000

    Sponsors and Collaborators

    • Assistance Publique - Hôpitaux de Paris

    Investigators

    • Principal Investigator: Claude Tayar, Assistance Publique - Hôpitaux de Paris

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Assistance Publique - Hôpitaux de Paris
    ClinicalTrials.gov Identifier:
    NCT00908193
    Other Study ID Numbers:
    • P051080
    First Posted:
    May 25, 2009
    Last Update Posted:
    Aug 2, 2013
    Last Verified:
    Jul 1, 2013

    Study Results

    No Results Posted as of Aug 2, 2013